Sentry LLC Eli Lilly & CO Transaction History

Sentry LLC

$519 Billion
Q3 2024

A detailed history of Sentry LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sentry LLC holds 5,005 shares of LLY stock, worth $3.92 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

5,005

Previous 5,004 0.02%

Holding current value

$3.92 Million

Previous $4.53 Billion 2.13%

% of portfolio

0.85%

Previous 0.83%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $772 - $960	1 Added 0.02%	5,005 $4.43 Billion
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $724 - $909	-1 Reduced 0.02%	5,004 $4.53 Billion
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $1,184 - $1,584	-2 Reduced 0.04%	5,005 $3.89 Billion
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $2.63 Million - $3.1 Million	5,007 New	5,007 $2.92 Million
Q1 2023 Mar 06, 2024	SELL	$310.63 - $364.82 $621 - $729	-2 Reduced 0.04%	5,005 $1.72 Billion

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.

Account